Jason Shand Robins's most recent trade in Ocular Therapeutix Inc was a trade of 15,441 Common Stock done . Disclosure was reported to the exchange on June 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc | Jason Shand Robins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 15,441 | 68,097 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Jason Shand Robins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 14,024 | 14,024 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Jason Shand Robins | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) |